JEADV
Journal of the European Academy of Dermatology and Venereology
READ THE LATEST ISSUE
JEADV July 2025
vol 39 Issue 8
JEADV is a high-ranking international journal publishing articles of general and practical interest in the field of dermatology and venereology including clinical and basic science topics, as well as research with practical implications. Our target audience is clinician dermatologists in hospitals or in private practice, as well as researchers and everybody interested in understanding the management of skin disease to improve patient outcomes.
JEADV aims to deliver the highest level of dermatological knowledge to its readership by publishing original articles, review articles, research letters, as well as editorials, commentaries and historical perspectives.
JEADV is the place where the European Clinical Guidelines derived from cooperation between the European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the Union Européenne des Médecins Spécialistes (UEMS), and other relevant subspecialty societies are published.
JEADV also has an Open Access companion title: JEADV Clinical Practice
Submit your paper to an internationally recognised Editorial team led by Professor Carle Paul for a chance at worldwide visibility thanks to Open Access
Read our Author Guidelines to learn more about the JEADV’s innovative article categories and how to best submit your paper for review.
- Why publish with JEADV?
- Why become a reviewer for JEADV?
Graphical Abstracts Gallery
July 2025
Non-invasive characterization of melanoma depth at single-cell resolution
Non-invasive determination of Breslow depth would be beneficial for the clinical management of melanoma. We demonstrate that RSOM can achieve non-invasive imaging of single melanocytes up to several millimetres in tissue. A pilot clinical study showed a high degree of correlation between RSOM and the standard for Breslow depth determination.
Non-invasive characterization of melanoma depth at single-cell resolution
Non-invasive determination of Breslow depth would be beneficial for the clinical management of melanoma. We demonstrate that RSOM can achieve non-invasive imaging of single melanocytes up to several millimetres in tissue. A pilot clinical study showed a high degree of correlation between RSOM and the standard for Breslow depth determination.
Infant palmar hyperlinearity and type 2 inflammatory markers predict atopic dermatitis at 1 year of age
Infant palmar hyperlinearity and elevated type 2 inflammatory markers at 2 months of age are associated with increased risk of developing atopic dermatitis by 1 year, suggesting a potential early-life clinical and immunological phenotype of AD.
Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance
When managing psoriasis, induced or exacerbated by ICI therapy for cancer, there are concerns regarding immunosuppression from systemic agents for the treatment of psoriasis and the potential impact on ICI efficacy. No direct, high-level evidence exists to address these concerns. ICI, immune checkpoint inhibitor; ICI-Ps, ICI-mediated psoriasis; IL, interleukin; PDE-4, phosphodiesterase-4; saPs, systemic agents for the treatment of psoriasis; TNF, tumour necrosis factor; TYK2, tyrosine kinase 2.
Trichophyton indotineae: Epidemiology, antifungal resistance and antifungal stewardship strategies
There is a concerning trend of widespread and severe superficial fungal infections caused by a new pathogen—Trichophyton indotineae—resistant to standard antifungal therapies. T. indotineae is now spreading globally and evolving. There is increasing urgency for healthcare providers and policy makers to initiate surveillance systems and antifungal stewardship programs.
JEADV Editorial Board
Editor-in-Chief
Carle Paul
Toulouse, France
Biography
Carle Paul has been Professor of Dermatology-Venereology at the University and Hospitals of Toulouse, France, since 2006. He holds a PhD in Skin Pharmacology from the University of Paris, France. His research interests include inflammatory skin diseases, pharmacology and drug development, emotional impact of skin diseases and leadership development. He has contributed to over 500 peer-reviewed scientific publications and has served on the editorial boards of several scientific journals.
In addition to his scientific activities, Carle has developed a special interest in mentoring young academic dermatologists. Since 2018, he has been a certified Emotional Intelligence (EI) coach (Daniel Goleman EI coaching programme). Carle studied leadership development with Georges Kohlrieser at IMD, Lausanne, Switzerland and graduated from the Advanced High Performance Leadership curriculum. Since 2015, he has been a member of the National University Council (CNU) in charge of mentoring and developing candidates for professor and associate professor positions in France. In collaboration with Michele Nevarez and the EADV Executive Committee, he created a European leadership development curriculum specifically for EADV members which runs annually.
Associate Editors
Rolland Gyulai
Szeged, Hungary
Biography
Rolland Gyulai is a board-certified dermato-venerologist and clinical oncologist with a deep interest in clinical and basic research, as well as undergraduate and graduate medical teaching. Dr. Gyulai is the author of more than 150 scientific papers and 10 book chapters, mainly in the field of immuno- and oncodermatology. He is currently a full professor and chairman of the Department of Dermatology and Allergology, University of Szeged, Hungary, the immediate past president of the Hungarian Dermatological Society, and past president of the German-Hungarian Dermatological Society.
Emek Kocatürk Göncü
Istanbul, Türkiye
Biography
Emek Kocatürk Göncü is Professor of Dermatology at Koç University School of Medicine in Istanbul, Turkey and a clinical researcher at Charite University Institute of Allergology, Berlin, Germany. Her clinical focus is on urticaria, contact/occupational dermatitis, itch, atopic dermatitis and psychodermatology. She is an author/co-author of more than 170 papers in peer-reviewed journals mostly on urticaria, atopic dermatitis and itch. Her recent research focuses on patient-reported outcome tools in chronic urticaria, hormonal effects on urticaria, COVID-19 and urticaria and inducible urticarias. She is a member of many scientific societies and acts as a steering committee member of the UCARE Network.
Jo Lambert
Ghent, Belgium
Biography
Jo Lambert is a senior full professor in dermatology and venereology, and chairing the Department of Dermatology at Ghent University, Ghent, Belgium. She is current chair of the EADV Task Force Psoriasis, EADV Scientific Programme Committee member and Councilor at the International Psoriasis Council. In the 2010s she served as associate editor and editorial assistant for the Journal of Investigative Dermatology, section on psoriasis and pigmentation.
She specialises in the fields of immune dermatoses and pigment cell research. Her research interests lie in improving care in immune-mediated inflammatory skin disorders: from advanced models of topical drug delivery to personalised dosing of biologicals. She founded the DermPlus approach, an example of a value-based integrated practice unit for immune-mediated chronic skin diseases. She has 270 publications, a total of 5842 times cited, and an H-index of 43.
Christian Posch
Vienna, Austria
Biography
Christian Posch is a board-certified physician-scientist with substantial productivity in basic, and clinical cancer research. His work focuses on signaling pathways. In previous studies, he has highlighted the critical role of the MAPK, PI3K/AKT/mTOR and cell cycle pathways for NRAS mutant melanoma maintenance. His paradigm-shifting findings help to explain differences in the sensitivity of NRAS mutant cells to specific small molecule inhibitors. Additionally, he has discovered that the negative regulator of (auto)-immunity, PD-1, also activates pro-tumorigenic, tumor cell intrinsic signaling events upon ligation with PDL1 or PDL2. From 2018-2022 he was the head of dermato-oncology at the Technical University of Munich. Since 2022 he has been the head of dermatology at the Vienna Healthcare Group, Austria.
Sarah Walsh
London, United Kingdom
Biography
Sarah Walsh is a consultant dermatologist at King’s College Hospital in London, where her principal clinical and research interests are in the domain of severe drug reactions, sarcoidosis, and biological therapies for psoriasis. She previously served as a Section Editor of the British Journal of Dermatology from 2011 – 2018.
She is the UK representative on the Board of the European Academy of Dermatovenereology. She is a member of the EADV Advocacy Working Group, and also chair of the EADV training course in Visual Literacy.
In her free time, she is a keen tennis and padel player, and skier, and enjoys the history of art.
Questions about the JEADV?
Join other EADV Members today to access the full exclusive content of the JEADV!
If you have any further questions, please contact us by clicking the button below.
